Neprilysin regulates amyloid β peptide levels

Journal of Molecular Neuroscience

Volumn 22, Issue 1-2, 2004, Pages 5-11

  Marr, Robert A ^a   Guan, Hanjun ^c   Rockenstein, Edward ^b   Kindy, Mark ^c,d   Gage, Fred H ^a   Verma, Inder ^a   Masliah, Eliezer ^b   Hersh, Louis B ^c  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

^d MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; LENTIVIRUS VECTOR; MEMBRANE METALLOENDOPEPTIDASE; ENZYME INHIBITOR;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL MODEL; BRAIN LEVEL; CHINESE HAMSTER; CONFERENCE PAPER; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; ENZYME DEGRADATION; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN CELL; MOUSE; NERVE CELL MEMBRANE CONDUCTANCE; NEUROTOXICITY; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; VIRAL GENE THERAPY; ANIMAL; ARTICLE; C57BL MOUSE; CELL CULTURE; CHO CELL; DISEASE MODEL; DOWN REGULATION; DRUG ANTAGONISM; DRUG RESISTANCE; FETUS; GENE THERAPY; GENE VECTOR; GENETICS; HAMSTER; LENTIVIRINAE; METABOLISM; METHODOLOGY; MOUSE MUTANT; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SENILE PLAQUE; TRANSGENIC MOUSE;

LENTIVIRUS; MUS MUSCULUS;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; CELLS, CULTURED; CHO CELLS; CRICETINAE; DISEASE MODELS, ANIMAL; DOWN-REGULATION; DRUG RESISTANCE; ENZYME INHIBITORS; FETUS; GENE THERAPY; GENETIC VECTORS; HIPPOCAMPUS; LENTIVIRUS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; NEPRILYSIN; SENILE PLAQUES;

EID: 3042819085     PISSN: 08958696     EISSN: None     Source Type: Journal    
DOI: 10.1385/JMN:22:1-2:5     Document Type: Conference Paper

References (16)

1. Dull T., Zufferey R., Kelly M., Mandel R. J., Nguyen M., Trono D., and Naldini L. (1998) A third-generation lentivirus vector with a conditional packaging system. J. Virol. 72, 8463-8471.
2. Hersh L. B. (1982) Degradation of enkephalins: the search for an enkephalinase. Mol. Cell. Biochem. 47, 35-43.
3. Hersh L. B. (2003) Peptidases, proteases and amyloid beta-peptide catabolism. Curr. Pharm. Des. 9, 449-454.
4. Holtzman, D. M., Bales, K. R., Paul, S. M., and DeMattos, R. B. (2002) Aβ immunization and anti-Aβ antibodies: potential therapies for the prevention and treatment of Alzheimer's disease. Adv. Drug Del. Rev. 54, 1603-1613.
5. Howell, S., Nalbantoglu, J., and Crine, P. (1995) Neutral endopeptidase can hydrolyze beta-amyloid(1-40) but shows no effect on beta-amyloid precursor protein metabolism. Peptides 16, 647-652.
6. Hsia A. Y., Masliah E ., McConlogue L., Yu G. Q., Tatsuno G., Hu K., et al. (1999) Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models. Proc. Natl. Acad. Sci. USA 96, 3228-3233.
7. Iwata N., Tsubuki S., Takaki Y., Watanabe K., Sekiguchi M., Hosoki E., et al. (2000) Identification of the major Abeta1-42-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition. Nat. Med. 6, 143-150.
8. Marr R. A., Rockenstein E,. Mukherjee A., Kindy M. S., Hersh L, B., Gage F. H., et al. (2003) Neprilysin gene transfer reduces human amyloid pathology in transgenic mice. J. Neurosci. 23, 1992-1996.
9. Masliah E., Sisk A., Mallory M., Mucke L., Schenk D., and Games D. (1996) Comparison of neurodegenerative pathology in transgenic mice overexpressing V717F beta-amyloid precursor protein and Alzheimer's disease. J. Neurosci. 16, 5795-5811.
10. Matsuoka Y., Saito M., LaFrancois J., Saito M., Gaynor K., Olm V., et al. (2003) Novel therapeutic approach for the treatment of Alzheimer's disease by peripheral administration of agents with an affinity to beta-amyloid. J. Neurosci. 23, 29-33.
11. Miyoshi H., Blomer U., Takahashi M., Gage F. H., and Verma I. M. (1998) Development of a self-inactivating lentivirus vector. J. Virol. 72, 8150-8157.
12. Mukherjee A. and Hersh L. B. (2002) Regulation of amyloid beta-peptide levels by enzymatic degradation. J Alzheimer's Dis. 4, 341-348.
13. Rockenstein E., Mallory M., Mante M., Sisk A., and Masliaha E. (2001) Early formation of mature amyloid-beta protein deposits in a mutant APP transgenic model depends on levels of Abeta(1-42). J. Neurosci Res. 66, 573-582.
14. Selkoe D. J. (1994) Cell biology of the amyloid beta-protein precursor and the mechanism of Alzheimer's disease. Annu. Rev. Cell Biol. 10, 373-403.
15. Yasojima, K., Akiyama, H. McGeer , E. G., and. McGeer, P. L. (2001a) Reduced neprilysin in high plaque areas of Alzheimer brain: a possible relationship to deficient degradation of beta-amyloid peptide. Neurosci. Lett. 297, 97-100.
16. Yasojima, K., McGeer , E. G., and. McGeer, P. L. (2001b) Relationship between beta amyloid peptide generating molecules and neprilysin in Alzheimer disease and normal brain. Brain Res. 919, 115-121.